drugset / Trial / NCT05331651
Effect of Glycopyrronium in Combination With Tropisetron in Anti-postoperative Nausea and Vomiting
Phase 4
Completed
480 enrolled
The Second Affiliated Hospital of Chongqing Medical University
Chongqing General Hospital · collabChongqing Jiangbei Hospital of Traditional Chinese Medicine · collabChongqing Liangping District People's Hospital · collabChongqing Medical University · collabChongqing Traditional Chinese Medicine Hospital · collabDepartment of Anesthesiology, Daping Hospital, Institute of Surgery Research, the Army Medical University · collabFirst Affiliated Hospital of Chongqing Medical University · collabFuling Hospital affiliated to Chongqing University · collabPeople's Hospital of Changshou Chongqing · collabPeople's Hospital of Chongqing Hechuan · collabPeople's Hospital of Shapingba District, Chongqing · collabPeople's Hospital of Xiushan County · collabQianjiang Central Hospital of Chongqing · collabStomatological Hospital of Chongqing Medical University · collabThe First People's Hospital Of Chongqing Liang Jiang New Area · collabThe Ninth People's Hospital of Chongqing · collabThe People's Hospital of Chongqing Kaizhou District · collabThe People's Hospital of DAZU ,Chongqing · collabThe People's Hospital of Nanchuan · collabThree Gorges Hospital of Chongqing University · collabWushan County People's Hospital · collab
RandomizedParallel-groupTriple-blindTreatment
Summary
To compare the anti-nausea and vomiting effect between glycopyrronium in combination with tropisetron and normal saline in combination with tropisetron for patients receiving elective surgery under general anesthesia. Based on this study the investigators intend to explore the feasibility of using glycopyrronium as adjuvant drug to prevent postoperative nausea and vomiting.
Timeline
- Start
- 2022-04-21
- Primary completion
- 2023-06-30
- Completion
- 2023-06-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Glycopyrronium | Unknown | 0.2 mg | Intravenous |
| Background | Tropisetron | Small molecule | 4 mg | Intravenous |
Indications
No indication recorded.